Introduction
In the recent decades, chronical heart failure has become a major reason for illness and death, which is sometimes caused by unrecognized atherothrombotic events. 1 Warfarin (3-(acetonylbenzyl)-4-hydroxycoumarin, WAR, see Fig. 1 ), a coumarin derivative, functions as a Vitamin K antagonist by inhibiting the Vitamin K conversion cycle, is capable of decreasing the probability of blood coagulation, which has been widely used as an oral anticoagulants for the treatment of many thrombotic diseases and the prevention of thromboembolic events. [2] [3] [4] However, the treatment with WAR is challenging due to its narrow therapeutic window, large inter-individual variability as well as main complication of bleeding and skin necrosis. 3 Aspirin (2-acetoxybenzoic acid, ASA, see Fig. 1 ), owing to its anticoagulant activity and prolonged effect, is widely used as a platelet inhibitor. 5 At the same time, several reports have compared the therapeutic effects of warfarin alone, aspirin alone or both. And most clinic trials have shown that warfarin plus low-dose aspirin not only might have an additive effect, but also calls for less intensive anticoagulation therapy. However, the risk of bleeding was greatly increased and excessive bleeding events often occur clinically when the doses of both are inappropriate or are not adjusted in time. [6] [7] [8] Therefore, the simultaneous quantitative analysis of WAR and ASA in biological fluids plays an extremely important role for the clinical administration.
Several analytic methods have been used for the determination of WAR contents in biological fluids, including highperformance liquid chromatography (HPLC) with fluorescence detection 9, 10 or ultraviolet detection, 11 multiwall carbon nanotubes and molecular imprinting 12 as well as micellar electrokinetic chromatography-mass spectrometry (MEKC-MS). 13 The simultaneous quantitative analysis of WAR and ASA was seldom reported, but a reversed-phase liquid chromatographic method was conducted for the determination of WAR and ASA in a combination tablet formulation. 14 The above methods usually involve complicated pretreatments or liquidchromatographic separation steps, which may cause deviation towards the predicted concentration level of the analytes, and bring some problems, such as environment pollution, a waste of organic solvents and time.
To the best of our knowledge, WAR and ASA both possess intrinsic fluorescence, but the spectra of both compounds overlap seriously, let alone the strong background fluorescence in human plasma and urine, making conventional fluorescence
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Keywords Warfarin, aspirin, excitation-emission matrix fluorescence, second-order calibration, alternating trilinear decomposition methods hard to quantify them in human plasma and urine. In the 1970s, excitation-emission matrix fluorescence (EEMs) was introduced by Christian et al., 15 which can provide more spectral and concentration information than the conventional singlewavelength fluorescent spectrometry, since an additional wavelength mode was included. Nevertheless, these fluorescence methods, which cannot provide moderate selectivity, are also unable to distinguish several compounds whose spectral are seriously overlapped, especially in complex matrices, without the help of complex pretreatments or other strategies. Fortunately, the combination of EEMs with second-order calibration methods have become a useful tool for quantitative analysis, which can allow analytes of interest to be quantitatively analyzed, even in the presence of uncalibrated or unknown interferents, without complicated pretreatment by adopting "mathematical separation" enhance or instead of "physical or chemical separation", and this unique property, namely "secondorder advantage". [16] [17] [18] This kind of analytical strategy has been widely used in many fields, such as pharmaceutical, environmental monitoring, food science and cosmetic industry. 16, 17, [19] [20] [21] [22] [23] [24] Meanwhile, many second-order calibration algorithms have been proposed, such as parallel factor analysisalternating least squares (PARAFAC-ALS), 25 alternating trilinear decomposition (ATLD) 26 and self-weighted alternating trilinear decomposition (SWATLD) 27 algorithm, promoting the development of second-order calibration methods in turn.
In the present work, a practical and simple method that combines excitation-emission matrix fluorescence with a second-order calibration method based on an alternating trilinear decomposition (ATLD) algorithm was developed to simultaneously and directly determine the WAR and ASA contents in human plasma and urine samples firstly. The use of EEMs methods obtain a lower limit of detection, and can be applied to the quantitative analysis of WAR and ASA in human plasma and urine clinically. In order to assess the accuracy and precision of the proposed method, the figure of merits were investigated. In addition, inter-and intra-day experiments were also conducted.
Theory

Trilinear component model for second-order calibration
According to the trilinear component model, two-way excitation-emission matrix fluorescence data may be obtained when a single sample is measured at I excitation wavelengths and J emission wavelengths, and the collection of K samples containing calibration and prediction sets can form a three-way data array X with a size of I × J × K. Then, each element of X can be expressed as:
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Here, xijk is the fluorescence intensity of sample k at excitation wavelength i and emission wavelength j; ain, bjn and ckn are the typical elements of the corresponding normalized excitation spectral matrix AI×N, normalized emission spectral matrix BI×N, and relative concentrations matrix CI×N, respectively; N denotes the total number of factors, including the components of interest and uncalibrated interferents in the complex matrices; eijk represents the element of the three-way residual data array E with the size of I × J × K.
ATLD algorithm
The alternating trilinear decomposition (ATLD) algorithm was proposed by Wu et al. 26 in the 1990s. It is based on the alternating least-squares principle to decompose a three-way data array, and utilizes the Moore-Penrose generalized inverse obtained by singular-value decomposition (SVD) to improve the iterative procedure. ATLD possesses the fastest convergence among iterative-type algorithms, and is insensitive to the preestimated number of components, which makes it be widely accepted and used in real cases. More detailed descriptions of ATLD algorithm were documented in the original literature.
16,26
Figures of merit
In fact, the figures of merit, such as sensitivity (SEN), selectivity (SEL), limit of detection (LOD) and limit of quantification (LOQ), are usually considered to be numerical parameters of an analytical method, which are used to characterize the performance of the calibration methods. Different approaches have been discussed in the literature to estimate the analytical figures of merit. 28 The SEN and SEL based on the concept of net analyte signal (NAS) that interpreted as the portion of the overall signal can been expressed as the follows: 28 
SENn = mn{[(Aexp
, (3) where mn is the total analyte signal for the analytes of interest at unit concentration; the subscript "nn" implies the (n, n) diagonal element of a matrix; the symbol " * " denotes the Hadamard matrix product; A and B are the matrices containing the profiles for all sample constituents in each data modes; the subscripts "exp" and "unx" indicate the expected and unexpected components, respectively; and I is an appropriately dimensioned unit matrix.
The limit of detection (LOD) and the limit of quantitation (LOQ) are estimated as follows:
Here, s(0) is the standard error of the predicted concentration for three different method blank samples, which can be computed by
where h is the leverage for the blank sample; sX 2 is the variance in instrumental signals and s0 2 is the variance in calibration concentrations.
Experimental
Reagents and chemicals
Warfarin (WAR, >99% purity) standards were obtained from Meilun Biological Technology Co., Ltd. (Dalian, China). Aspirin (ASA, 99.5% purity) standards were purchased from Dr. Ehrenstorfer GmbH (Augsburg, Germany). Methanol and acetonitrile of analytical grade were purchased from Oceanpak (Goteborg, Sweden). Ultrapure water was prepared by a Milli-Q water purification system (Millipore, USA). Stock solutions of WAR (155.7 nmol L -1 ) and ASA (305.3 nmol L -1 ) were prepared in a 10.00-mL brown volumetric flask with methanol solvent, and then stored in a refrigerator at 4 C, respectively. Urine samples were obtained from healthy volunteers with centrifugation for 20 min, taking the supernatant for determination. The human plasma was obtained from Jiufeng Bio-Technology Co., Ltd. (Beijing, China) and stored at -20 C in a refrigerator. In order to precipitate protein, acetonitrile was added into the human plasma at a volume ratio of 2:1 with sonication for 20 min, and centrifuged for 15 min at 4000 r min -1 , then obtain the supernatant. 30 Apparatus and software All EEM measurements were carried out on an F-7000 fluorescence spectrophotometer (Hitachi, Japan) equipped with a Xenon lamp and a 1.00-cm quartz cell. The excitationemission fluorescence matrices were recorded every 2 nm with the excitation wavelength ranging 220 -350 nm and the emission over 320 -500 nm. The scanning rate was 12000 nm min -1 , and the detector voltage was 750 V. The monochromator slit widths for the excitation and emission were both 5.0 nm. All of the spectral data were saved and exported with the text format.
The programs used in this work were written by our group under the MATLAB (Mathworks, Inc., MA, USA) environment, and performed on a personal computer with the Windows 7 operating system.
Three-way EEMs data array
Working solutions of WAR and ASA were prepared by diluting their stock solutions with methanol to suitable concentrations, respectively. A seven-sample calibration set for ASA was built. Moreover, a validation set (V01 -V03) without any interferences was designed containing the analytes of three concentration levels (low, medium and high concentration) within the corresponding calibration ranges, which was conducted so as to validate the accuracy of the established model. In order to assess the quantitative analysis performance of the proposed method in human plasma samples, a five-sample set (P01 -P05) was built by adding different amounts of WAR and ASA together with 400 μL plasma, and then were diluted to 10.00 mL with methanol in volumetric flasks. Similarly, another five-sample set (U01 -U05) of human urine was also prepared with the urine volume of 150 μL. Finally, three blank plasma and three blank urine samples as well as two samples containing only one analyte, respectively, for the reference spectra of analytes were prepared as the test set. Therefore, an excitation-emission-sample three-way data array (67 × 92 × 18) could be constructed for each predicted set. All of the concentration designs are listed in Table 1 .
Data preprocessing
The Rayleigh and Raman scatting were existed in all samples within the selected wavelength ranges. These nonlinear factors can make the three-way EEM data array deviate from the trilinear component model, which may lead to a deviation to the quantitative results. Thus, these nonlinear data were truncated in human plasma samples. Meanwhile, we also handled these scattering by interpolation 31 in human urine samples, which retained more information of the quantitative analysis. The first-order Rayleigh width is [15, 15] , Raman width is [5, 5] , and the second-order Rayleigh width is [15, 15] in this work. Both of the data preprocessing methods have achieved satisfying results as discussed in the next section.
Results and Discussion
Characteristics of spectra Figure 2 shows the excitation-emission matrix fluorescence spectra of WAR and ASA, the spiked plasma sample (P05) and the spiked urine sample (U05). As depicted in Figs. 2(A) and 2(B), WAR possesses a fluorescence peak at about 300 nm (excitation) and 390 nm (emission), and that of ASA is located at 290 nm (excitation) and 400 nm (emission). Obviously, the fluorescence spectra of the two analytes of interest overlapped with each other seriously in both the excitation and emission modes. In addition, as demonstrated in Figs. 2(C) and 2(D), we can only see one peak for the spiked plasma sample P05, even though several fluorescence responsive constituents coexisted, which indicates that the fluorescence spectra of the components in the spiked human plasma sample overlapped seriously; so does the human urine sample. Under this circumstance, conventional univariate calibration method cannot quantify these overlapped analytes directly without any previous separation process. However, with the application of secondorder calibration based on the ATLD algorithm, a satisfactory quantitative result of analytes can be obtained, even in the presence of uncalibrated interferences, owing to the well-known "second-order advantage".
Testing the calibration model
A good model is the premise of accurate predictions. A threesample validation set (V01 -V03) was constructed to test the calibration model. The average recoveries (mean ± standard deviation) of the validation set were 101.4 ± 5.6, 103.3 ± 4.9% for WAR and 102.9 ± 1.3, 103.4 ± 0.7% for ASA in human plasma and urine samples, respectively. The RMSEVs were 9.54, 7.14 nmol L -1 for WAR and 6.93, 9.10 nmol L -1 for ASA, respectively, which validated the accuracy of the proposed model 
Simultaneous quantitative analysis of WAR and ASA in human plasma and urine samples
As mentioned above, ATLD algorithm is insensitive to the pre-estimated number of components. In this work, we chose the component number of 4 by experience to decompose the EEMs data array, and the normalized resolved excitation profiles, emission profiles and relative concentration information were obtained, which are shown in Fig. 3 (A1) -(C1) for human plasma samples and (A2) -(C2) for human urine samples, respectively. As can be seen, the resolved excitation and emission profiles for two components were in good agreement with their actual ones based on the system of pure standards. Moreover, the fluorescence spectra of the human plasma and urine overlapped with the analytes of interest, especially in the excitation mode, respectively, which is clearly illustrated in Fig. 3 . Depending on the relative concentration information extracted by ATLD algorithm, the predicted concentration were obtained with the linear univariate regression, and the average recoveries (mean ± standard deviation) as well as RMSEPs for the spiked human plasma and urine samples based on ATLD algorithm (N = 4) are given in Table 2 . It is worth noting that the recoveries of ASA were a little poor, especially in human urine samples, which may result from a greater degree of overlap with the fluorescence background and its relative lower concentration. All in all, the favorable results with recoveries of around 100% demonstrated that excitation-emission matrix fluorescence coupling with the second-order calibration method based on the ATLD algorithm is capable of quantifying analytes of interest in complex biological fluids, even in the presence of unknown interference and collinearity.
According to the reported literature, 32, 33 the plasma concentrations of WAR and ASA were about 2000 -9000 and 600 -27000 nmol L -1 for patients with pharmaceuticals treatment, respectively, and the human plasma was 50-fold diluted in this experiment. In present work, the concentration ranges in calibration set were 46.70 -467.0 nmol L -1 for WAR and 37.74 -377.4 nmol L -1 for ASA, which met the requirements for quantitative analysis of WAR and ASA in human plasma clinically.
Figures of merit
To evaluate the performance of the proposed method with second-order calibration based on the ATLD algorithm, the figures of merit, such as SEN, SEL, LOD and LOQ, for different biological fluids were calculated and are summarized in Table 3 .
As can be seen, the figures of merit for ASA were better than those of WAR, attributed to its intensive fluorescence intensity, which can provide more quantitative information. Furthermore, the LODs and LOQs of ASA and WAR in human plasma samples were lower than those in human urine samples, which corresponds to the actual concentrations in real biological fluids. These satisfactory results indicated that the proposed method possesses the ability to quantify analytes of interest in complex matrices.
Intra-and inter-day assays
In order to test the repeat-ability of the proposed method, three replicates of each spiked samples with the concentration level of low, medium and high were prepared and analyzed by the ATLD algorithm over a single day for the human plasma and urine samples, respectively. Moreover, to explore the reproducibility of the proposed method, three replicates of spiked samples were freshly prepared and analyzed over three consecutive days. The average recoveries and relative standard deviation (RSD) are summarized in Table 4 . As can be seen, the results for both human plasma and urine samples are acceptable, which demonstrates that the proposed second-order calibration method based on the ATLD algorithm is reliable. In addition, the RSDs of ASA were lower than that of WAR generally, which recalled the results of the figures of merit as mentioned above.
Conclusions
In the present work, a practical method that combines excitationemission matrix fluorescence with a second-order calibration method based on the alternating trilinear decomposition (ATLD) algorithm was successfully developed to simultaneously determine warfarin (WAR) and aspirin (ASA) contents in human plasma and urine. The average recoveries, the figures of merit as well as the results of intra-and inter-day assays for predicted sets have validated the accuracy, repeat-ability and reproducibility of the proposed method. The analytical method is fast, practical, sensitive and low-cost. Further, thanks to the well-known "second-order advantage", it allows analytes of interest to be quantitatively analyzed in complex matrices, even in the presence of uncalibrated or unknown interferents without any complicated pretreatment by employing "mathematical separation" instead of "physical or chemical separation". Overall, the proposed method can be an excellent alternative for the simultaneous determination of WAR and ASA contents in real biological fluids, and can provide important guidance for clinical administration.
